nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—HTR1A—bipolar disorder	0.315	0.399	CbGaD
Lurasidone—DRD2—bipolar disorder	0.267	0.339	CbGaD
Lurasidone—HTR2A—bipolar disorder	0.207	0.262	CbGaD
Lurasidone—HTR7—locus ceruleus—bipolar disorder	0.011	0.147	CbGeAlD
Lurasidone—HTR2A—locus ceruleus—bipolar disorder	0.00684	0.092	CbGeAlD
Lurasidone—HTR7—autonomic nervous system—bipolar disorder	0.00583	0.0784	CbGeAlD
Lurasidone—HTR1A—telencephalic ventricle—bipolar disorder	0.00545	0.0732	CbGeAlD
Lurasidone—HTR7—telencephalic ventricle—bipolar disorder	0.0052	0.0699	CbGeAlD
Lurasidone—DRD2—telencephalic ventricle—bipolar disorder	0.00492	0.0661	CbGeAlD
Lurasidone—HTR2A—autonomic nervous system—bipolar disorder	0.00364	0.0489	CbGeAlD
Lurasidone—HTR2A—telencephalic ventricle—bipolar disorder	0.00325	0.0436	CbGeAlD
Lurasidone—HTR2A—urine—bipolar disorder	0.00296	0.0398	CbGeAlD
Lurasidone—CYP3A4—urine—bipolar disorder	0.00274	0.0369	CbGeAlD
Lurasidone—HTR1A—blood plasma—bipolar disorder	0.0026	0.0349	CbGeAlD
Lurasidone—HTR7—blood plasma—bipolar disorder	0.00248	0.0333	CbGeAlD
Lurasidone—Ziprasidone—DRD5—bipolar disorder	0.00204	0.252	CrCbGaD
Lurasidone—ADRA2A—blood plasma—bipolar disorder	0.00182	0.0244	CbGeAlD
Lurasidone—HTR2A—blood plasma—bipolar disorder	0.00155	0.0208	CbGeAlD
Lurasidone—CYP3A4—blood plasma—bipolar disorder	0.00143	0.0192	CbGeAlD
Lurasidone—ADRA2C—adrenal cortex—bipolar disorder	0.00116	0.0156	CbGeAlD
Lurasidone—Ziprasidone—DRD4—bipolar disorder	0.00104	0.129	CrCbGaD
Lurasidone—Ziprasidone—DRD3—bipolar disorder	0.000898	0.111	CrCbGaD
Lurasidone—Ziprasidone—DRD1—bipolar disorder	0.000881	0.109	CrCbGaD
Lurasidone—HTR1A—nervous system—bipolar disorder	0.000772	0.0104	CbGeAlD
Lurasidone—Ziprasidone—HTR2C—bipolar disorder	0.000754	0.0935	CrCbGaD
Lurasidone—HTR7—nervous system—bipolar disorder	0.000738	0.00991	CbGeAlD
Lurasidone—Ziprasidone—HTR1A—bipolar disorder	0.000732	0.0907	CrCbGaD
Lurasidone—HTR1A—cerebellum—bipolar disorder	0.000727	0.00976	CbGeAlD
Lurasidone—DRD2—nervous system—bipolar disorder	0.000698	0.00937	CbGeAlD
Lurasidone—HTR7—cerebellum—bipolar disorder	0.000694	0.00933	CbGeAlD
Lurasidone—ADRA2C—nervous system—bipolar disorder	0.000678	0.00911	CbGeAlD
Lurasidone—DRD2—cerebellum—bipolar disorder	0.000656	0.00882	CbGeAlD
Lurasidone—ADRA2A—thyroid gland—bipolar disorder	0.000643	0.00864	CbGeAlD
Lurasidone—ADRA2C—cerebellum—bipolar disorder	0.000638	0.00857	CbGeAlD
Lurasidone—Ziprasidone—SLC6A4—bipolar disorder	0.000625	0.0775	CrCbGaD
Lurasidone—Ziprasidone—DRD2—bipolar disorder	0.000621	0.077	CrCbGaD
Lurasidone—HTR1A—brain—bipolar disorder	0.00059	0.00793	CbGeAlD
Lurasidone—HTR7—brain—bipolar disorder	0.000564	0.00758	CbGeAlD
Lurasidone—ADRA2A—nervous system—bipolar disorder	0.000541	0.00727	CbGeAlD
Lurasidone—DRD2—brain—bipolar disorder	0.000533	0.00716	CbGeAlD
Lurasidone—ADRA2C—brain—bipolar disorder	0.000518	0.00696	CbGeAlD
Lurasidone—ADRA2A—cerebellum—bipolar disorder	0.000509	0.00684	CbGeAlD
Lurasidone—Ziprasidone—HTR2A—bipolar disorder	0.00048	0.0595	CrCbGaD
Lurasidone—HTR2A—nervous system—bipolar disorder	0.00046	0.00618	CbGeAlD
Lurasidone—HTR2A—cerebellum—bipolar disorder	0.000433	0.00582	CbGeAlD
Lurasidone—CYP3A4—nervous system—bipolar disorder	0.000426	0.00572	CbGeAlD
Lurasidone—ADRA2A—brain—bipolar disorder	0.000414	0.00556	CbGeAlD
Lurasidone—HTR2A—brain—bipolar disorder	0.000352	0.00473	CbGeAlD
Lurasidone—DRD2—Signaling by GPCR—HTR1A—bipolar disorder	3.2e-05	0.000248	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—DRD4—bipolar disorder	3.2e-05	0.000248	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD5—bipolar disorder	3.19e-05	0.000247	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RGS4—bipolar disorder	3.18e-05	0.000247	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DGKH—bipolar disorder	3.17e-05	0.000246	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—IMPA2—bipolar disorder	3.15e-05	0.000245	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HTR1A—bipolar disorder	3.15e-05	0.000245	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—TAC1—bipolar disorder	3.15e-05	0.000244	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—HTR1A—bipolar disorder	3.15e-05	0.000244	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—DRD4—bipolar disorder	3.14e-05	0.000244	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RGS4—bipolar disorder	3.12e-05	0.000243	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—ADCY2—bipolar disorder	3.11e-05	0.000242	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—TAC1—bipolar disorder	3.1e-05	0.000241	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—TAC1—bipolar disorder	3.1e-05	0.000241	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—DRD1—bipolar disorder	3.09e-05	0.00024	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HTR2C—bipolar disorder	3.09e-05	0.00024	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CLOCK—bipolar disorder	3.09e-05	0.00024	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—DRD2—bipolar disorder	3.08e-05	0.000239	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HTR2C—bipolar disorder	3.04e-05	0.000236	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD1—bipolar disorder	3.04e-05	0.000236	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—HTR2C—bipolar disorder	3.04e-05	0.000236	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD1—bipolar disorder	3.04e-05	0.000236	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—ADCY2—bipolar disorder	3.01e-05	0.000234	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—ADCY2—bipolar disorder	3.01e-05	0.000234	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—TSHB—bipolar disorder	3.01e-05	0.000233	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—TPH2—bipolar disorder	3.01e-05	0.000233	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CACNB2—bipolar disorder	3.01e-05	0.000233	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—DRD3—bipolar disorder	2.99e-05	0.000232	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—DRD2—bipolar disorder	2.98e-05	0.000231	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—ADCY2—bipolar disorder	2.96e-05	0.00023	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—DPYD—bipolar disorder	2.96e-05	0.00023	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD3—bipolar disorder	2.95e-05	0.000229	CbGpPWpGaD
Lurasidone—DRD2—GPCR ligand binding—POMC—bipolar disorder	2.95e-05	0.000229	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD3—bipolar disorder	2.94e-05	0.000228	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—DRD2—bipolar disorder	2.93e-05	0.000227	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—HTR2A—bipolar disorder	2.91e-05	0.000226	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—DRD4—bipolar disorder	2.9e-05	0.000225	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HTR1A—bipolar disorder	2.9e-05	0.000225	CbGpPWpGaD
Lurasidone—HTR2A—GPCR ligand binding—POMC—bipolar disorder	2.9e-05	0.000225	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD5—bipolar disorder	2.9e-05	0.000225	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HTR1A—bipolar disorder	2.86e-05	0.000222	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD4—bipolar disorder	2.86e-05	0.000222	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TAC1—bipolar disorder	2.86e-05	0.000222	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD4—bipolar disorder	2.86e-05	0.000222	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RGS4—bipolar disorder	2.84e-05	0.000221	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—TAC1—bipolar disorder	2.82e-05	0.000219	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD1—bipolar disorder	2.8e-05	0.000218	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HTR2C—bipolar disorder	2.8e-05	0.000218	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TRPC3—bipolar disorder	2.79e-05	0.000217	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HTR2C—bipolar disorder	2.76e-05	0.000215	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD1—bipolar disorder	2.76e-05	0.000215	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—CACNA1C—bipolar disorder	2.75e-05	0.000214	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—ADCY2—bipolar disorder	2.73e-05	0.000212	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NTRK2—bipolar disorder	2.73e-05	0.000212	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD3—bipolar disorder	2.71e-05	0.000211	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TRPC3—bipolar disorder	2.7e-05	0.00021	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—GSK3A—bipolar disorder	2.7e-05	0.00021	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—ADCY2—bipolar disorder	2.69e-05	0.000209	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—ADCY2—bipolar disorder	2.69e-05	0.000209	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PIK3C2A—bipolar disorder	2.68e-05	0.000208	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD3—bipolar disorder	2.68e-05	0.000208	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—ADM—bipolar disorder	2.67e-05	0.000207	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—DRD2—bipolar disorder	2.67e-05	0.000207	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—DRD2—bipolar disorder	2.66e-05	0.000207	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR ligand binding—POMC—bipolar disorder	2.64e-05	0.000205	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD4—bipolar disorder	2.64e-05	0.000205	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD4—bipolar disorder	2.6e-05	0.000202	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TSHB—bipolar disorder	2.6e-05	0.000202	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PDE4B—bipolar disorder	2.6e-05	0.000202	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TACR1—bipolar disorder	2.6e-05	0.000202	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—ADM—bipolar disorder	2.58e-05	0.0002	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—POMC—bipolar disorder	2.56e-05	0.000199	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TSHB—bipolar disorder	2.51e-05	0.000195	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PDE4B—bipolar disorder	2.51e-05	0.000195	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TACR1—bipolar disorder	2.51e-05	0.000195	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CLOCK—bipolar disorder	2.51e-05	0.000195	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—ADCY2—bipolar disorder	2.48e-05	0.000193	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TCF7L2—bipolar disorder	2.47e-05	0.000192	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—DRD2—bipolar disorder	2.45e-05	0.000191	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TRPC3—bipolar disorder	2.45e-05	0.000191	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—ADCY2—bipolar disorder	2.45e-05	0.00019	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—TPH2—bipolar disorder	2.44e-05	0.00019	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—TSHB—bipolar disorder	2.44e-05	0.00019	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CACNB2—bipolar disorder	2.44e-05	0.00019	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—DRD2—bipolar disorder	2.42e-05	0.000188	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TRPC3—bipolar disorder	2.41e-05	0.000187	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—SNAP25—bipolar disorder	2.4e-05	0.000187	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—DPYD—bipolar disorder	2.4e-05	0.000187	CbGpPWpGaD
Lurasidone—CYP3A4—Biological oxidations—POMC—bipolar disorder	2.38e-05	0.000185	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—HTR2A—bipolar disorder	2.38e-05	0.000184	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ADM—bipolar disorder	2.34e-05	0.000182	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—POMC—bipolar disorder	2.32e-05	0.00018	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADM—bipolar disorder	2.3e-05	0.000179	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—HTR2A—bipolar disorder	2.3e-05	0.000178	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TSHB—bipolar disorder	2.28e-05	0.000177	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PDE4B—bipolar disorder	2.28e-05	0.000177	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TACR1—bipolar disorder	2.28e-05	0.000177	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TSHB—bipolar disorder	2.24e-05	0.000174	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PDE4B—bipolar disorder	2.24e-05	0.000174	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TACR1—bipolar disorder	2.24e-05	0.000174	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—CACNA1C—bipolar disorder	2.23e-05	0.000173	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NTRK1—bipolar disorder	2.22e-05	0.000173	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TRPC3—bipolar disorder	2.2e-05	0.000171	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PIK3C2A—bipolar disorder	2.18e-05	0.000169	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—S100B—bipolar disorder	2.16e-05	0.000168	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—HTR2A—bipolar disorder	2.16e-05	0.000167	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—IMPA1—bipolar disorder	2.13e-05	0.000165	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—ADCY2—bipolar disorder	2.13e-05	0.000165	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TAC1—bipolar disorder	2.12e-05	0.000164	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ADM—bipolar disorder	2.1e-05	0.000163	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—HTR2A—bipolar disorder	2.09e-05	0.000162	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	2.09e-05	0.000162	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR1A—bipolar disorder	2.08e-05	0.000162	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HTR2C—bipolar disorder	2.08e-05	0.000161	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD1—bipolar disorder	2.08e-05	0.000161	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TAC1—bipolar disorder	2.05e-05	0.000159	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	2.04e-05	0.000159	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TSHB—bipolar disorder	2.04e-05	0.000159	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TACR1—bipolar disorder	2.04e-05	0.000159	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NTRK2—bipolar disorder	2.02e-05	0.000157	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD3—bipolar disorder	2.01e-05	0.000156	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR2C—bipolar disorder	2.01e-05	0.000156	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD1—bipolar disorder	2.01e-05	0.000156	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—GSK3A—bipolar disorder	2e-05	0.000156	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NTRK2—bipolar disorder	1.96e-05	0.000152	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD4—bipolar disorder	1.95e-05	0.000152	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—SNAP25—bipolar disorder	1.95e-05	0.000152	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD3—bipolar disorder	1.95e-05	0.000151	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—GSK3A—bipolar disorder	1.94e-05	0.00015	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—NRG1—bipolar disorder	1.91e-05	0.000148	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—POMC—bipolar disorder	1.9e-05	0.000147	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	1.89e-05	0.000147	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD4—bipolar disorder	1.89e-05	0.000147	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR1A—bipolar disorder	1.89e-05	0.000147	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	1.87e-05	0.000145	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TAC1—bipolar disorder	1.86e-05	0.000144	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HTR1A—bipolar disorder	1.86e-05	0.000144	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—ADCY2—bipolar disorder	1.84e-05	0.000143	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—POMC—bipolar disorder	1.84e-05	0.000143	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TCF7L2—bipolar disorder	1.83e-05	0.000142	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TAC1—bipolar disorder	1.83e-05	0.000142	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DRD1—bipolar disorder	1.82e-05	0.000142	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR2C—bipolar disorder	1.82e-05	0.000142	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—COMT—bipolar disorder	1.82e-05	0.000141	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—DRD2—bipolar disorder	1.82e-05	0.000141	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NDUFV2—bipolar disorder	1.81e-05	0.000141	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—MAOA—bipolar disorder	1.81e-05	0.00014	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD1—bipolar disorder	1.79e-05	0.000139	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—HTR2C—bipolar disorder	1.79e-05	0.000139	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—ADCY2—bipolar disorder	1.78e-05	0.000138	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NTRK2—bipolar disorder	1.77e-05	0.000138	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TCF7L2—bipolar disorder	1.77e-05	0.000138	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DRD3—bipolar disorder	1.77e-05	0.000137	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—DRD2—bipolar disorder	1.76e-05	0.000137	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—GSK3A—bipolar disorder	1.76e-05	0.000137	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AKR1C4—bipolar disorder	1.75e-05	0.000136	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NTRK2—bipolar disorder	1.75e-05	0.000136	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD3—bipolar disorder	1.74e-05	0.000135	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	1.73e-05	0.000134	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ADCY2—bipolar disorder	1.73e-05	0.000134	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—POMC—bipolar disorder	1.72e-05	0.000134	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—HTR2A—bipolar disorder	1.72e-05	0.000134	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—DRD4—bipolar disorder	1.71e-05	0.000133	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	1.7e-05	0.000132	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	1.69e-05	0.000131	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD4—bipolar disorder	1.69e-05	0.000131	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—POMC—bipolar disorder	1.67e-05	0.000129	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—POMC—bipolar disorder	1.67e-05	0.000129	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	1.66e-05	0.000129	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	1.65e-05	0.000128	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	1.64e-05	0.000127	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	1.63e-05	0.000127	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	1.63e-05	0.000127	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ADCY2—bipolar disorder	1.61e-05	0.000125	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	1.61e-05	0.000125	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—S100B—bipolar disorder	1.6e-05	0.000124	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NTRK1—bipolar disorder	1.59e-05	0.000124	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	1.59e-05	0.000123	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	1.59e-05	0.000123	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	1.58e-05	0.000123	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	1.58e-05	0.000123	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.58e-05	0.000122	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	1.57e-05	0.000122	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—DRD2—bipolar disorder	1.57e-05	0.000122	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—S100B—bipolar disorder	1.55e-05	0.00012	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	1.53e-05	0.000119	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—POMC—bipolar disorder	1.51e-05	0.000117	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NCAN—bipolar disorder	1.51e-05	0.000117	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	1.49e-05	0.000116	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—POMC—bipolar disorder	1.49e-05	0.000116	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—COMT—bipolar disorder	1.48e-05	0.000115	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SLC5A3—bipolar disorder	1.48e-05	0.000115	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—MTHFR—bipolar disorder	1.47e-05	0.000114	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—MAOA—bipolar disorder	1.47e-05	0.000114	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NTRK1—bipolar disorder	1.45e-05	0.000112	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	1.44e-05	0.000112	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	1.44e-05	0.000112	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	1.43e-05	0.000111	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	1.42e-05	0.00011	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NRG1—bipolar disorder	1.41e-05	0.00011	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—S100B—bipolar disorder	1.41e-05	0.000109	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—GSK3B—bipolar disorder	1.38e-05	0.000107	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—S100B—bipolar disorder	1.38e-05	0.000107	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—POMC—bipolar disorder	1.37e-05	0.000107	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NRG1—bipolar disorder	1.37e-05	0.000106	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—INS—bipolar disorder	1.37e-05	0.000106	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	1.35e-05	0.000105	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	1.29e-05	0.000101	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	1.27e-05	9.89e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—S100B—bipolar disorder	1.26e-05	9.77e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NRG1—bipolar disorder	1.24e-05	9.63e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—HTR2A—bipolar disorder	1.23e-05	9.57e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NRG1—bipolar disorder	1.22e-05	9.48e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—MTHFR—bipolar disorder	1.2e-05	9.29e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—POMC—bipolar disorder	1.18e-05	9.14e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—INS—bipolar disorder	1.17e-05	9.09e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—HTR2A—bipolar disorder	1.12e-05	8.69e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	1.11e-05	8.62e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CLOCK—bipolar disorder	1.07e-05	8.29e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TSHB—bipolar disorder	1.04e-05	8.08e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—TPH2—bipolar disorder	1.04e-05	8.08e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.04e-05	8.08e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	1.03e-05	7.97e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—DPYD—bipolar disorder	1.02e-05	7.95e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—POMC—bipolar disorder	1.02e-05	7.9e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—INS—bipolar disorder	1.01e-05	7.86e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	1e-05	7.78e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—GSK3B—bipolar disorder	9.93e-06	7.71e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—POMC—bipolar disorder	9.85e-06	7.65e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—INS—bipolar disorder	9.79e-06	7.6e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—POMC—bipolar disorder	9.57e-06	7.43e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CACNA1C—bipolar disorder	9.52e-06	7.39e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—INS—bipolar disorder	9.51e-06	7.39e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	9.27e-06	7.2e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—GSK3B—bipolar disorder	9.01e-06	6.99e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—POMC—bipolar disorder	8.93e-06	6.94e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—INS—bipolar disorder	8.89e-06	6.9e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	8.86e-06	6.88e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—POMC—bipolar disorder	8.79e-06	6.83e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—INS—bipolar disorder	8.74e-06	6.79e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SNAP25—bipolar disorder	8.32e-06	6.46e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	8.06e-06	6.26e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—POMC—bipolar disorder	8e-06	6.21e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—INS—bipolar disorder	7.95e-06	6.18e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ADCY2—bipolar disorder	7.36e-06	5.72e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—COMT—bipolar disorder	6.3e-06	4.89e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MAOA—bipolar disorder	6.26e-06	4.86e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MTHFR—bipolar disorder	5.1e-06	3.96e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—POMC—bipolar disorder	4.08e-06	3.16e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—INS—bipolar disorder	4.05e-06	3.15e-05	CbGpPWpGaD
